Krystal Biotech
KRYS
KRYS
13 hedge funds and large institutions have $34M invested in Krystal Biotech in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.99% less ownership
Funds ownership: 32.6% → 31.6% (-0.99%)
Holders
13
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$779K | |
| 2 | +$526K | |
| 3 | +$266K | |
| 4 |
Squarepoint
New York
|
+$114K |
| 5 |
TCP
Tourbillon Capital Partners
New York
|
+$24.7K |
Top Sellers
| 1 | -$534K | |
| 2 | -$137K | |
| 3 | -$26K | |
| 4 |
FMA
FNY Managed Accounts
New York
|
-$23K |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$5K |